BenevolentAI
how approach compares to industry typical proportion of targets validated by lab assay potential increase in chance of a drug reaching the market industry time from target to candidate yrs potential time saved relative to industry at least yrs cost from target to potential cost bene per relative to industry saving cee yrs | BenevolentAI
Company
Deck date
November 2022
Slide
8 of 17
Similar slides by BenevolentAI
Investor Presentation
October 2022
Investor Day
September 2022
Related slides by other companies
Activist
October 2018
Investor Day
March 2022
Investor Presentation
August 2023
Start Up
December 2018
Other recent decks by BenevolentAI
Investor Presentation
September 2024
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies